These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 16281308)
21. Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity. Jin YR; Im JH; Park ES; Cho MR; Han XH; Lee JJ; Lim Y; Kim TJ; Yun YP J Cardiovasc Pharmacol; 2008 Jan; 51(1):45-54. PubMed ID: 18209568 [TBL] [Abstract][Full Text] [Related]
22. Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents. Liu G; Xu J; Chen N; Zhang S; Ding Z; Du H Eur J Med Chem; 2012 Jul; 53():114-23. PubMed ID: 22531380 [TBL] [Abstract][Full Text] [Related]
23. New class of potent antinociceptive and antiplatelet 10H-phenothiazine-1-acylhydrazone derivatives. Silva GA; Costa LM; Brito FC; Miranda AL; Barreiro EJ; Fraga CA Bioorg Med Chem; 2004 Jun; 12(12):3149-58. PubMed ID: 15158783 [TBL] [Abstract][Full Text] [Related]
24. Cyclic guanidines: synthesis and antiplatelet activity of 4,6,7,8-tetrahydro-1H-imidazo[1,2-a]pyrazolo[3,4-d]pyrimidin-7-ones and 1,4,6,7,8,9-hexahydropyrazolo [3',4':4,5]pyrimido[2,1-c] [1,2,4]triazin-7-ones. Ferroni R; Simoni D; Orlandini P; Bardi A; Franze GP; Guarneri M Arzneimittelforschung; 1990 Dec; 40(12):1328-31. PubMed ID: 2095128 [TBL] [Abstract][Full Text] [Related]
25. [PAF-antagonists with lipid structure. 6. Alkylpropandiol lipids with acyl- and ether- structures at the C-3 position and heterocyclic head groups; synthesis, characterization and structure-activity relationship]. Kertscher HP Pharmazie; 1997 Sep; 52(9):672-5. PubMed ID: 9411454 [TBL] [Abstract][Full Text] [Related]
26. Amidinosemicarbazido derivatives of pyrazole: synthesis and inhibitory effect on blood coagulation and platelet aggregation. Ferroni R; Milani L; Simoni D; Orlandini P; Poli T; Guarneri M; Taddeo U Farmaco Sci; 1988 Nov; 43(11):891-9. PubMed ID: 3251783 [TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and in vitro activities on anti-platelet aggregation of 4-methoxybenzene-1,3-isophthalamides. Liu XJ; Shi XX; Zhong YL; Liu N; Liu K Bioorg Med Chem Lett; 2012 Nov; 22(21):6591-5. PubMed ID: 23010272 [TBL] [Abstract][Full Text] [Related]
28. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase. Liu FC; Liao CH; Chang YW; Liou JT; Day YJ Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675 [TBL] [Abstract][Full Text] [Related]
31. Novel synthetic approach to N-aryl-4-(3-pyridyl)thiazol-2-amine and analogues using HMCM-41 as catalyst, and their biological evaluation as human platelet aggregation inhibitors. Bhoga U Eur J Med Chem; 2007 Aug; 42(8):1144-50. PubMed ID: 17350143 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955 [TBL] [Abstract][Full Text] [Related]
33. Synthesis, DNA-PK inhibition, anti-platelet activity studies of 2-(N-substituted-3-aminopyridine)-substituted-1,3-benzoxazines and DNA-PK and PI3K inhibition, homology modelling studies of 2-morpholino-(7,8-di and 8-substituted)-1,3-benzoxazines. Ihmaid SK; Al-Rawi JM; Bradley CJ; Angove MJ; Robertson MN Eur J Med Chem; 2012 Nov; 57():85-101. PubMed ID: 23059543 [TBL] [Abstract][Full Text] [Related]
34. Synthesis, antiplatelet and vasorelaxing activities of xanthone derivatives. Lin KW; Fang SC; Hung CF; Shieh BJ; Yang SC; Teng CM; Lin CN Arch Pharm (Weinheim); 2009 Jan; 342(1):19-26. PubMed ID: 19035386 [TBL] [Abstract][Full Text] [Related]
35. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets. Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903 [TBL] [Abstract][Full Text] [Related]
36. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets. Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439 [TBL] [Abstract][Full Text] [Related]
37. Antiplatelet activity of beta-carboline alkaloids from Perganum harmala: a possible mechanism through inhibiting PLCgamma2 phosphorylation. Im JH; Jin YR; Lee JJ; Yu JY; Han XH; Im SH; Hong JT; Yoo HS; Pyo MY; Yun YP Vascul Pharmacol; 2009; 50(5-6):147-52. PubMed ID: 19073282 [TBL] [Abstract][Full Text] [Related]